ID   ADCY1_HUMAN             Reviewed;        1119 AA.
AC   Q08828; A4D2L8; Q75MI1;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   12-APR-2005, sequence version 2.
DT   10-MAY-2017, entry version 160.
DE   RecName: Full=Adenylate cyclase type 1;
DE            EC=4.6.1.1 {ECO:0000250|UniProtKB:P19754};
DE   AltName: Full=ATP pyrophosphate-lyase 1;
DE   AltName: Full=Adenylate cyclase type I;
DE   AltName: Full=Adenylyl cyclase 1;
DE   AltName: Full=Ca(2+)/calmodulin-activated adenylyl cyclase;
GN   Name=ADCY1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 281-1119, AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=8314585; DOI=10.1006/geno.1993.1213;
RA   Villacres E.C., Xia Z., Bookbinder L.H., Edelhoff S., Disteche C.M.,
RA   Storm D.R.;
RT   "Cloning, chromosomal mapping, and expression of human fetal brain
RT   type I adenylyl cyclase.";
RL   Genomics 16:473-478(1993).
RN   [4]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11549699; DOI=10.1210/jcem.86.9.7837;
RA   Cote M., Guillon G., Payet M.D., Gallo-Payet N.;
RT   "Expression and regulation of adenylyl cyclase isoforms in the human
RT   adrenal gland.";
RL   J. Clin. Endocrinol. Metab. 86:4495-4503(2001).
RN   [5]
RP   INVOLVEMENT IN DFNB44.
RX   PubMed=24482543; DOI=10.1093/hmg/ddu042;
RA   Santos-Cortez R.L., Lee K., Giese A.P., Ansar M., Amin-Ud-Din M.,
RA   Rehn K., Wang X., Aziz A., Chiu I., Hussain Ali R., Smith J.D.,
RA   Shendure J., Bamshad M., Nickerson D.A., Ahmed Z.M., Ahmad W.,
RA   Riazuddin S., Leal S.M.;
RT   "Adenylate cyclase 1 (ADCY1) mutations cause recessive hearing
RT   impairment in humans and defects in hair cell function and hearing in
RT   zebrafish.";
RL   Hum. Mol. Genet. 23:3289-3298(2014).
CC   -!- FUNCTION: Catalyzes the formation of the signaling molecule cAMP
CC       in response to G-protein signaling. Mediates responses to
CC       increased cellular Ca(2+)/calmodulin levels (By similarity). May
CC       be involved in regulatory processes in the central nervous system.
CC       May play a role in memory and learning. Plays a role in the
CC       regulation of the circadian rhythm of daytime contrast sensitivity
CC       probably by modulating the rhythmic synthesis of cyclic AMP in the
CC       retina (By similarity). {ECO:0000250|UniProtKB:O88444,
CC       ECO:0000250|UniProtKB:P19754}.
CC   -!- CATALYTIC ACTIVITY: ATP = 3',5'-cyclic AMP + diphosphate.
CC       {ECO:0000250|UniProtKB:P19754}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P19754};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:P19754};
CC       Note=Binds 2 magnesium ions per subunit. Is also active with
CC       manganese (in vitro). {ECO:0000250|UniProtKB:P30803};
CC   -!- ENZYME REGULATION: Activated by calcium/calmodulin. Activated by
CC       forskolin. Activated by the G protein alpha subunit GNAS.
CC       Inhibited by the G protein beta and gamma subunit complex.
CC       Inhibited by the ATP analogs adenosine, 2'-deoxyadenosine and 2'-
CC       deoxy-3'-AMP. {ECO:0000250|UniProtKB:P19754}.
CC   -!- SUBUNIT: Interacts with CALM. {ECO:0000250|UniProtKB:P19754}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:P19754};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:P19754}. Cell
CC       membrane {ECO:0000269|PubMed:11549699}; Multi-pass membrane
CC       protein {ECO:0000305}. Cytoplasm {ECO:0000250|UniProtKB:O88444}.
CC       Membrane raft {ECO:0000250|UniProtKB:P19754}. Note=Expressed in
CC       the cytoplasm of supporting cells and hair cells of the cochlea
CC       vestibule, as well as to the cochlear hair cell nuclei and
CC       stereocilia. {ECO:0000250|UniProtKB:O88444}.
CC   -!- TISSUE SPECIFICITY: Detected in zona glomerulosa and zona
CC       fasciculata in the adrenal gland (at protein level)
CC       (PubMed:11549699). Brain, retina and adrenal medulla.
CC       {ECO:0000269|PubMed:11549699, ECO:0000269|PubMed:8314585}.
CC   -!- DOMAIN: The protein contains two modules with six transmembrane
CC       helices each; both are required for catalytic activity. Isolated
CC       N-terminal or C-terminal guanylate cyclase domains have no
CC       catalytic activity, but when they are brought together, enzyme
CC       activity is restored. The active site is at the interface of the
CC       two domains. Both contribute substrate-binding residues, but the
CC       catalytic metal ions are bound exclusively via the N-terminal
CC       guanylate cyclase domain. {ECO:0000250|UniProtKB:P30803}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:P19754}.
CC   -!- DISEASE: Deafness, autosomal recessive, 44 (DFNB44) [MIM:610154]:
CC       A form of non-syndromic deafness characterized by prelingual
CC       profound hearing loss affecting all frequencies.
CC       {ECO:0000269|PubMed:24482543}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl
CC       cyclase family. {ECO:0000255|PROSITE-ProRule:PRU00099}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC069008; AAS07467.1; -; Genomic_DNA.
DR   EMBL; AC091439; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH236960; EAL23741.1; -; Genomic_DNA.
DR   EMBL; L05500; AAA02907.1; -; mRNA.
DR   CCDS; CCDS34631.1; -.
DR   PIR; A47007; A47007.
DR   RefSeq; NP_066939.1; NM_021116.2.
DR   UniGene; Hs.192215; -.
DR   ProteinModelPortal; Q08828; -.
DR   SMR; Q08828; -.
DR   STRING; 9606.ENSP00000297323; -.
DR   BindingDB; Q08828; -.
DR   ChEMBL; CHEMBL2899; -.
DR   DrugBank; DB00131; Adenosine monophosphate.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   iPTMnet; Q08828; -.
DR   PhosphoSitePlus; Q08828; -.
DR   BioMuta; ADCY1; -.
DR   DMDM; 62512172; -.
DR   PaxDb; Q08828; -.
DR   PeptideAtlas; Q08828; -.
DR   PRIDE; Q08828; -.
DR   Ensembl; ENST00000297323; ENSP00000297323; ENSG00000164742.
DR   GeneID; 107; -.
DR   KEGG; hsa:107; -.
DR   UCSC; uc003tne.5; human.
DR   CTD; 107; -.
DR   DisGeNET; 107; -.
DR   GeneCards; ADCY1; -.
DR   H-InvDB; HIX0033533; -.
DR   HGNC; HGNC:232; ADCY1.
DR   HPA; CAB018364; -.
DR   HPA; HPA068274; -.
DR   MalaCards; ADCY1; -.
DR   MIM; 103072; gene.
DR   MIM; 610154; phenotype.
DR   neXtProt; NX_Q08828; -.
DR   OpenTargets; ENSG00000164742; -.
DR   Orphanet; 90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB.
DR   PharmGKB; PA24560; -.
DR   eggNOG; KOG3619; Eukaryota.
DR   eggNOG; COG2114; LUCA.
DR   GeneTree; ENSGT00760000119042; -.
DR   HOGENOM; HOG000006941; -.
DR   HOVERGEN; HBG050458; -.
DR   InParanoid; Q08828; -.
DR   KO; K08041; -.
DR   OMA; CLPWAWS; -.
DR   OrthoDB; EOG091G05JR; -.
DR   PhylomeDB; Q08828; -.
DR   TreeFam; TF313845; -.
DR   BRENDA; 4.6.1.1; 2681.
DR   Reactome; R-HSA-163359; Glucagon signaling in metabolic regulation.
DR   Reactome; R-HSA-163615; PKA activation.
DR   Reactome; R-HSA-164378; PKA activation in glucagon signalling.
DR   Reactome; R-HSA-170660; Adenylate cyclase activating pathway.
DR   Reactome; R-HSA-170670; Adenylate cyclase inhibitory pathway.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   Reactome; R-HSA-418597; G alpha (z) signalling events.
DR   Reactome; R-HSA-432040; Vasopressin regulates renal water homeostasis via Aquaporins.
DR   Reactome; R-HSA-442720; CREB phosphorylation through the activation of Adenylate Cyclase.
DR   Reactome; R-HSA-5610787; Hedgehog 'off' state.
DR   SIGNOR; Q08828; -.
DR   ChiTaRS; ADCY1; human.
DR   GeneWiki; ADCY1; -.
DR   GenomeRNAi; 107; -.
DR   PRO; PR:Q08828; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000164742; -.
DR   CleanEx; HS_ADCY1; -.
DR   ExpressionAtlas; Q08828; baseline and differential.
DR   Genevisible; Q08828; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0008074; C:guanylate cyclase complex, soluble; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0004016; F:adenylate cyclase activity; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008294; F:calcium- and calmodulin-responsive adenylate cyclase activity; ISS:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0004383; F:guanylate cyclase activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007190; P:activation of adenylate cyclase activity; TAS:Reactome.
DR   GO; GO:0034199; P:activation of protein kinase A activity; TAS:Reactome.
DR   GO; GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0007409; P:axonogenesis; IEA:Ensembl.
DR   GO; GO:0006171; P:cAMP biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0019933; P:cAMP-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB.
DR   GO; GO:1904322; P:cellular response to forskolin; ISS:UniProtKB.
DR   GO; GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome.
DR   GO; GO:0006182; P:cGMP biosynthetic process; IBA:GO_Central.
DR   GO; GO:0007623; P:circadian rhythm; IEA:Ensembl.
DR   GO; GO:0007616; P:long-term memory; IEA:Ensembl.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0003091; P:renal water homeostasis; TAS:Reactome.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0010226; P:response to lithium ion; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   Gene3D; 3.30.70.1230; -; 2.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR018297; A/G_cyclase_CS.
DR   InterPro; IPR032628; AC_N.
DR   InterPro; IPR030672; Adcy.
DR   InterPro; IPR029787; Nucleotide_cyclase.
DR   Pfam; PF16214; AC_N; 1.
DR   Pfam; PF00211; Guanylate_cyc; 2.
DR   PIRSF; PIRSF039050; Ade_cyc; 1.
DR   SMART; SM00044; CYCc; 2.
DR   SUPFAM; SSF55073; SSF55073; 2.
DR   PROSITE; PS00452; GUANYLATE_CYCLASE_1; 2.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 2.
PE   1: Evidence at protein level;
KW   ATP-binding; Biological rhythms; Calmodulin-binding;
KW   cAMP biosynthesis; Cell membrane; Complete proteome; Cytoplasm;
KW   Deafness; Glycoprotein; Lyase; Magnesium; Manganese; Membrane;
KW   Metal-binding; Non-syndromic deafness; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1   1119       Adenylate cyclase type 1.
FT                                /FTId=PRO_0000195682.
FT   TOPO_DOM      1     63       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     64     84       Helical. {ECO:0000255}.
FT   TRANSMEM     88    108       Helical. {ECO:0000255}.
FT   TRANSMEM    125    145       Helical. {ECO:0000255}.
FT   TRANSMEM    158    178       Helical. {ECO:0000255}.
FT   TRANSMEM    183    203       Helical. {ECO:0000255}.
FT   TRANSMEM    214    234       Helical. {ECO:0000255}.
FT   TOPO_DOM    235    610       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    611    631       Helical. {ECO:0000255}.
FT   TRANSMEM    635    655       Helical. {ECO:0000255}.
FT   TRANSMEM    674    694       Helical. {ECO:0000255}.
FT   TRANSMEM    725    745       Helical. {ECO:0000255}.
FT   TRANSMEM    753    773       Helical. {ECO:0000255}.
FT   TRANSMEM    775    794       Helical. {ECO:0000255}.
FT   TOPO_DOM    795   1119       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     308    313       ATP. {ECO:0000250|UniProtKB:P30803}.
FT   NP_BIND     350    352       ATP. {ECO:0000250|UniProtKB:P30803}.
FT   NP_BIND     997    999       ATP. {ECO:0000250|UniProtKB:P26769}.
FT   NP_BIND    1004   1008       ATP. {ECO:0000250|UniProtKB:P26769}.
FT   REGION      493    520       Interaction with calmodulin.
FT                                {ECO:0000250}.
FT   REGION     1024   1047       Interaction with calmodulin.
FT                                {ECO:0000250}.
FT   METAL       308    308       Magnesium 1; catalytic.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00099}.
FT   METAL       308    308       Magnesium 2; catalytic.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00099}.
FT   METAL       309    309       Magnesium 2; via carbonyl oxygen;
FT                                catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00099}.
FT   METAL       352    352       Magnesium 1; catalytic.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00099}.
FT   METAL       352    352       Magnesium 2; catalytic.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00099}.
FT   BINDING     396    396       ATP. {ECO:0000250|UniProtKB:P30803}.
FT   BINDING     920    920       ATP. {ECO:0000250|UniProtKB:P26769}.
FT   BINDING    1044   1044       ATP. {ECO:0000250|UniProtKB:P26769}.
FT   MOD_RES     551    551       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88444}.
FT   CARBOHYD    704    704       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     456    456       P -> L (in dbSNP:rs12721473).
FT                                /FTId=VAR_029186.
FT   VARIANT     940    940       A -> T (in dbSNP:rs45444695).
FT                                /FTId=VAR_029187.
FT   VARIANT     984    984       V -> M (in dbSNP:rs2293106).
FT                                /FTId=VAR_048246.
SQ   SEQUENCE   1119 AA;  123440 MW;  E8DDC8FCB58743D7 CRC64;
     MAGAPRGGGG GGGGAGEPGG AERAAGTSRR RGLRACDEEF ACPELEALFR GYTLRLEQAA
     TLKALAVLSL LAGALALAEL LGAPGPAPGL AKGSHPVHCV LFLALLVVTN VRSLQVPQLQ
     QVGQLALLFS LTFALLCCPF ALGGPARGSA GAAGGPATAE QGVWQLLLVT FVSYALLPVR
     SLLAIGFGLV VAASHLLVTA TLVPAKRPRL WRTLGANALL FVGVNMYGVF VRILTERSQR
     KAFLQARSCI EDRLRLEDEN EKQERLLMSL LPRNVAMEMK EDFLKPPERI FHKIYIQRHD
     NVSILFADIV GFTGLASQCT AQELVKLLNE LFGKFDELAT ENHCRRIKIL GDCYYCVSGL
     TQPKTDHAHC CVEMGLDMID TITSVAEATE VDLNMRVGLH TGRVLCGVLG LRKWQYDVWS
     NDVTLANVME AAGLPGKVHI TKTTLACLNG DYEVEPGYGH ERNSFLKTHN IETFFIVPSH
     RRKIFPGLIL SDIKPAKRMK FKTVCYLLVQ LMHCRKMFKA EIPFSNVMTC EDDDKRRALR
     TASEKLRNRS SFSTNVVYTT PGTRVNRYIS RLLEARQTEL EMADLNFFTL KYKHVEREQK
     YHQLQDEYFT SAVVLTLILA ALFGLVYLLI FPQSVVVLLL LVFCICFLVA CVLYLHITRV
     QCFPGCLTIQ IRTVLCIFIV VLIYSVAQGC VVGCLPWAWS SKPNSSLVVL SSGGQRTALP
     TLPCESTHHA LLCCLVGTLP LAIFFRVSSL PKMILLSGLT TSYILVLELS GYTRTGGGAV
     SGRSYEPIVA ILLFSCALAL HARQVDIRLR LDYLWAAQAE EEREDMEKVK LDNRRILFNL
     LPAHVAQHFL MSNPRNMDLY YQSYSQVGVM FASIPNFNDF YIELDGNNMG VECLRLLNEI
     IADFDELMEK DFYKDIEKIK TIGSTYMAAV GLAPTSGTKA KKSISSHLST LADFAIEMFD
     VLDEINYQSY NDFVLRVGIN VGPVVAGVIG ARRPQYDIWG NTVNVASRMD STGVQGRIQV
     TEEVHRLLRR CPYHFVCRGK VSVKGKGEML TYFLEGRTDG NGSQIRSLGL DRKMCPFGRA
     GLQGRRPPVC PMPGVSVRAG LPPHSPGQYL PSAAAGKEA
//
